Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-06

Clinical Trial Update: Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating re-treatment with Cimzia in chronic plaque psoriasis; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Pharma | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-06